luvixasertib   Click here for help

GtoPdb Ligand ID: 11664

Synonyms: CFI-402257 | CFI402257 | compound 24 [PMID: 27437075]
Compound class: Synthetic organic
Comment: CFI-402257 is an orally bioavailable, and somewhat selective type 1.5 inhibitor of threonine tyrosine kinase (TTK) [1-2]. TTK inhibitors are under investigation as anticancer agents. CFI-402257 induces chromosome missegregation and aneuploidy which lead to cell death. We matched CFI-402257's chemical structure to the INN 'luvixasertib' that was released in the WHO's proposed INN list 127 (21 July 2022).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 113.67
Molecular weight 498.24
XLogP 4.6
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1ccc(cc1C)c1cnn2c1nc(Oc1cccnc1)cc2NCC1CC(C1)(C)O)NC1CC1
Isomeric SMILES Cc1c(ccc(c1)c1c2nc(cc(n2nc1)NCC1CC(C1)(C)O)Oc1cnccc1)C(=O)NC1CC1
InChI InChI=1S/C28H30N6O3/c1-17-10-19(5-8-22(17)27(35)32-20-6-7-20)23-16-31-34-24(30-14-18-12-28(2,36)13-18)11-25(33-26(23)34)37-21-4-3-9-29-15-21/h3-5,8-11,15-16,18,20,30,36H,6-7,12-14H2,1-2H3,(H,32,35)
InChI Key PMQUGSPFUBGJCZ-UHFFFAOYSA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel